KLEMP WALTER V 4
4 · Moleculin Biotech, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
KLEMP WALTER V
DirectorCEO and President
Transactions
- Tax Payment
Common Stock
2025-06-16$0.69/sh−406$278→ 58,296 total - Exercise/Conversion
Restricted Stock Units
2025-06-16−1,667→ 370,075 total→ Common Stock (1,667 underlying) - Exercise/Conversion
Common Stock
2025-06-16+1,667→ 58,702 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards
- [F3]On June 16, 2021, the reporting person was granted 6,668 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.